Extrapulomnary-extragastrointestinal manifestations in patients with COVID-19
Keywords:
Clinical severity, COVID-19, Extra-gastrointestinal, Extra-pulmonaryAbstract
Background: COVID-19 (coronavirus disease-2019) is a multisystem disorder. In terms of severity, the disease can manifest as mild, moderate, severe, or critical. Depending on the severity of the case, the patient may exhibit extrapulmonary or extragastrointestinal symptoms. Objective: The purpose of this research was to evaluate the extrapulmonary and extragastrointestinal symptoms of COVID-19 infection in patients and to make accurate predictions for follow-up care. Patient and method: This prospective observational study was conducted on (404) COVID-19 infected patients with positive COVID-19 PCR at El-sheikh Zayed Al-Nahyan Hospital from January 1st to June 30th, 2021. Results: There was a statistically significant difference between the clinical severity of illness regrding patient demographic features such as older age, male gender, co morbidities such as diabetes and hypertension; extra pulmonary – extra gastrointestinal manifestations. Conclusion: There is a correlation between COVID-19 illness that is severe and critical and the presence of preexisting conditions such as diabetes and cardiovascular disease, as well as older age, fatigue, anorexia, abdominal pain, diarrhoea, expectoration, dyspnea, chest pain, altered mental status, morbilliform rash, acute kidney injury, acute cardiac injury, and eye manifestations.
Downloads
References
Machhi, Jatin. “The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections.” Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology, 2020; 15(3): 359-386. doi:10.1007/s11481-020-09944-5
Zou X. “Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.” Frontiers of medicine, 2020: 14(2): 185-192. doi:10.1007/s11684-020-0754-0
Elrobaa, Islam H, Karl J. “COVID-19: Pulmonary and Extra Pulmonary Manifestations.” Frontiers in public health 2021; 9: 711616. doi:10.3389/fpubh.2021.711616
Shimaa E, Ibrahim A, Marwa S, Walaa E, Mohamed A, Amany G, et al. "Clinical and Laboratory Predictors for ICU Admission among COVID-19 Infected Egyptian Patients, A multi-Center Study ". Afro-Egyptian Journal of Infectious and Endemic Diseases, 2021; 11(3): 284-294. doi: 10.21608/aeji.2021.82473.1155
Jia He, Bo Wu. Characteristic electrocardiographic manifestations in patients with COVID-19. Can J Cardiol. 2020; 36: 966.e1–966.e4.
Spiezia L. “COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.” Thrombosis and haemostasis. 2020; 120 (6): 998-1000. doi:10.1055/s-0040-1710018
Wang Ming-Ke. “COVID-19 and the digestive system: A comprehensive review.” World journal of clinical cases, 2021; 9(16): 3796-3813. doi:10.12998/wjcc.v9.i16.3796
Immacolata A, Elena B. Gender differences in patients with COVID-19: a narrative review. Monaldi Arch Chest Dis. 2020; 90: 318–24.
Mao R. “Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.” The lancet. Gastroenterology & hepatology. 2020; 5(7): 667-678. doi:10.1016/S2468-1253(20)30126-6
Ghweil Ali A. “Characteristics, Outcomes and Indicators of Severity for COVID-19 among Sample of ESNA Quarantine Hospital's Patients, Egypt: A Retrospective Study.” Infection and drug resistance. 2020; 13: 2375-2383. doi:10.2147/IDR.S263489
Omran D. “Predictors of severity and development of critical illness of Egyptian COVID-19 patients: A multicenter study.” PloS one. 2021; 16(9): e0256203., doi:10.1371/journal.pone.0256203
Mubarik S. “The Association of Hypertension with the Severity of and Mortality From the COVID-19 in the Early Stage of the Epidemic in Wuhan, China: A Multicenter Retrospective Cohort Study.” Frontiers in medicine. 2021; 8(6): 23608. doi:10.3389/fmed.2021.623608
Guido J, Guido G. Age and Multimorbidity Predict Death Among COVID-19 Patients. Results of the SARS-RAS Study of the Italian Society of Hypertension. Hypertension. 2020; 76:366–372
He Xiaobo. “Clinical Symptom Differences between Mild and Severe COVID-19 Patients in China: A Meta-Analysis.” Frontiers in public health. 2021; 8: 561264. doi:10.3389/fpubh.2020.561264
Xu Wan. “Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning.” Scientific reports. 2021; 11(1): 2933. doi:10.1038/s41598-021-82492-x
Weibiao Z, Kai Qi. Gastrointestinal symptoms are associated with severity of coronavirus disease 2019: a systematic review and meta-analysis, European Journal of Gastroenterology & Hepatology: February 2022; 34(2): 168-176 doi: 10.1097/MEG.0000000000002072
Mao L. “Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China.” JAMA neurology. 2020; 77(6): 683-690. doi:10.1001/jamaneurol.2020.1127
Merkler A. “Risk of Ischemic Stroke in Patients with Covid-19 versus Patients with Influenza.” medRxiv: the preprint server for health sciences 2020; 05(18): 20105494. doi:10.1101/2020.05.18.20105494. Preprint.
Sarkar D. “Ocular manifestations of RT-PCR-confirmed COVID-19 cases in a large database cross-sectional study.” BMJ open ophthalmology. 2021; 6(1): e000775. doi:10.1136/bmjophth-2021-000775
Dockery DM. “The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention.” The Journal of emergency medicine. 2020; 59(1): 137-140. doi:10.1016/j.jemermed.2020.04.060
Muhammad A. “Dermatological Manifestations of COVID-19 in Patients Reporting to a Tertiary Care Hospital in Rawalpindi, Pakistan.” Cureus. 2021; 13(10): e18973. doi:10.7759/cureus.18973
Méndez M. “Skin manifestations in patients hospitalized with confirmed COVID-19 disease: a cross-sectional study in a tertiary hospital.” International journal of dermatology. 2020; 59(11): 1353-1357. doi:10.1111/ijd.15180
Fei Z, Ting Yu. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England).2020; 395(10229): 1054–1062.
Shi S. “Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China.” JAMA cardiology. 2020; 5(7): 802-810. doi:10.1001/jamacardio.2020.0950
Ferguson J. “Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.” Emerging infectious diseases. 2020; 26(8): 1679-1685. doi:10.3201/eid2608.201776
Grillet F. “Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected with Pulmonary CT Angiography.” Radiology. 2020; 296(3): E186-E188. doi:10.1148/radiol.2020201544
Yildirim C. “Early predictors of acute kidney injury in COVID-19 patients.” Nephrology (Carlton, Vic.). 2021; 26(6): 513-521. doi:10.1111/nep.13856
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.








